Genetic screening on health council agenda:
This article was originally published in Clinica
Executive Summary
The implications of genetic screening is one of the key issues on the agenda at the seventh conference of European Health Ministers on June 12 and 13. The meeting, entitled Health, Dignity and Human Rights will also discuss the organisation and financing of healthcare services, as well as how to forge alliances between countries to respond effectively on a pan-European level to global health threats, such as the SARS virus. The conference is expected to call on the Council of Europe to pursue and intensify its work on the social, ethical and human rights dimension in the planning, delivery and availability of healthcare.
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.